Description
PRIME SUS 500
- Propionate 50mg
- Phenylpropionate 100mg
- Isocaproate 150mg
- Decanoate 200mg
PRIME SUS 500 offers a high-dose blend of four testosterone esters: Testosterone Propionate, Phenylpropionate, Isocaproate, and Decanoate; designed to provide both fast-acting and long-lasting anabolic activity in a single formulation. Developed for advanced users who demand efficient and sustained hormonal support.
Mechanism of Action:
The ester combination allows for rapid onset from the shorter esters while the longer esters maintain stable blood levels over time. This pharmacokinetic profile ensures continuous anabolic stimulation, enhancing nitrogen retention, strength output, and muscle protein synthesis.
Use Case:
Optimal for long-duration mass-building protocols, especially when injection frequency needs to be minimized without sacrificing hormonal balance. Frequently favored by experienced users who seek a versatile, single-vial solution covering both short- and long-acting testosterone support.
Advantages of High-Concentration Format:
At 500mg/ml, PRIME SUS 500 enables simplified dosing and reduced injection frequency while still delivering a potent hormonal impact. This makes it particularly efficient for stacking in complex cycles where volume management is critical.
All products sold by ORYVION are intended for laboratory research purposes only and are not approved for human consumption, medical use, or veterinary applications. These compounds are not classified as dietary supplements or pharmaceuticals.
ORYVION operates strictly within the legal frameworks of the jurisdictions in which it conducts business. Sales are limited to countries and regions where the possession and use of research chemicals are permitted by law. It is the sole responsibility of the purchaser to ensure compliance with local, national, and international laws and regulations.
By purchasing, the customer affirms that they are at least 21 years of age, legally authorized to receive such materials, and fully aware of their intended use. ORYVION disclaims all liability for misuse, improper handling, or any consequences resulting from non-compliant use of these products.
ORYVION complies with relevant provisions under EU’s Pharmaceutical and Medical Device Act, as well as applicable international guidelines regarding non-pharmaceutical research compounds.